Bristol Myers Squibb (BMY)

Purchases of Investments

-$3.59B

TTM · Period ending: · USD

BMY logo

BMY Purchases of Investments

Latest reported-$3.59B
BMY TTM Purchases of Investments (-$1.33B → -$3.59B)
High-resolution chart · PNG

BMY purchases of investments history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bristol Myers Squibb Purchases of Investments — Trailing twelve months (TTM) (USD)
Period endingPurchases of Investments (USD)
-3,594,000,000
-2,145,000,000
-2,000,000,000
-2,293,000,000
-1,668,000,000
-1,131,000,000
-769,000,000
-1,115,000,000
-1,577,000,000
-1,848,000,000
-1,774,000,000
-1,083,000,000
-855,000,000
-2,078,000,000
-3,592,000,000
-5,636,000,000
-6,427,000,000
-5,890,000,000
-5,478,000,000
-4,432,000,000
-4,558,000,000
-4,739,000,000
-4,172,000,000
-5,467,000,000
-5,481,000,000
-4,454,000,000
-3,961,000,000
-2,885,000,000
-2,295,000,000
-2,262,000,000
-2,305,000,000
-2,065,000,000
-2,843,000,000
-4,518,000,000
-5,437,000,000
-5,275,000,000
-4,935,000,000
-3,770,000,000
-3,089,000,000
-3,108,000,000
-2,866,000,000
-2,845,000,000
-3,143,000,000
-3,191,000,000
-4,183,000,000
-5,460,000,000
-5,719,000,000
-5,222,000,000
-4,017,000,000
-2,661,000,000
-1,859,000,000
-1,554,000,000
-1,031,000,000
-1,270,000,000
-3,607,000,000
-4,976,000,000
-6,058,000,000
-7,200,000,000
-6,819,000,000
-7,464,000,000
-6,423,000,000
-5,177,000,000
-5,823,000,000
-4,874,000,000
-5,163,000,000
-5,499,000,000
-3,489,000,000
-2,492,000,000
-2,012,000,000
-1,244,000,000
-422,000,000
-20,123,000,000
-19,930,000,000
-19,924,000,000
-19,878,000,000
-3,000,000
-271,000,000
47,000,000
-6,000,000
-8,000,000
-9,000,000
-58,000,000
-30,000,000
50,000,000
-132,000,000
-267,000,000
-779,000,000
-24,343,000,000
-24,501,000,000
-24,392,000,000
-24,281,000,000
-945,000,000
-610,000,000
-686,000,000
-381,000,000
-1,693,000,000
-2,065,000,000
-2,193,000,000
-2,582,000,000
-1,120,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.